Compass Therapeutics Inc. (CMPX) Social Stream
COMPASS THERAPEUTICS INC (CMPX) Price Targets From Analysts
Use the tables below to see what analysts covering COMPASS THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-16 | 1 | $11 | $11 | $11 | $1.55 | 609.68% |
2021-11-19 | 3 | $15 | $11 | $13 | $1.55 | 738.71% |
2021-12-15 | 4 | $15 | $8 | $11.333 | $1.55 | 631.16% |
2021-12-20 | 4 | $15 | $8 | $11.5 | $1.55 | 641.94% |
2021-12-22 | 6 | $15 | $5 | $10.2 | $1.55 | 558.06% |
2022-01-12 | 7 | $15 | $5 | $10.333 | $1.55 | 566.65% |
2022-01-19 | 7 | $15 | $5 | $10.285 | $1.55 | 563.55% |
2022-02-04 | 7 | $12 | $5 | $9.857 | $1.55 | 535.94% |
2022-02-08 | 7 | $12 | $5 | $9.428 | $1.55 | 508.26% |
2022-03-21 | 8 | $12 | $5 | $9.125 | $1.55 | 488.71% |
2022-04-28 | 7 | $12 | $5 | $8.857 | $1.55 | 471.42% |
2022-05-12 | 7 | $12 | $5 | $9.142 | $1.55 | 489.81% |
2022-05-23 | 8 | $12 | $5 | $9.428 | $1.55 | 508.26% |
2022-08-02 | 7 | $12 | $5 | $9.285 | $1.55 | 499.03% |
2022-10-26 | 6 | $12 | $5 | $9.166 | $1.55 | 491.35% |
2022-11-03 | 6 | $12 | $5 | $8.833 | $1.55 | 469.87% |
2022-11-10 | 6 | $12 | $7 | $9.333 | $1.55 | 502.13% |
2022-11-14 | 6 | $12 | $8 | $9.666 | $1.55 | 523.61% |
2022-12-16 | 7 | $12 | $8 | $9.757 | $1.55 | 529.48% |
2023-01-18 | 7 | $11 | $8 | $9.46 | $1.55 | 510.32% |
2023-01-27 | 8 | $11 | $8 | $9.383 | $1.55 | 505.35% |
2023-05-04 | 8 | $11 | $8 | $9.185 | $1.55 | 492.58% |
2023-11-09 | 6 | $11 | $8 | $9.4 | $1.55 | 506.45% |
The Trend in the Analyst Price Target
CMPX's average price target has moved up $0.23 over the prior 13 months.
CMPX reports an average of 295.17% for its upside potential over the past 42 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-18 | 6 | 11 | 8 | 9.383 | 4.21 | 122.87% |
2023-01-27 | 7 | 11 | 8 | 9.383 | 3.94 | 138.15% |
2023-03-15 | 8 | 11 | 8 | 9.185 | 3.56 | 158.01% |
2023-10-01 | 8 | 11 | 8 | 9.328 | 1.97 | 373.5% |
2023-11-09 | 6 | 11 | 8 | 9.328 | 1.61 | 479.38% |
CMPX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.38 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
CMPX's average broker recommendation rating worsened by 0.12 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, COMPASS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3309.73% of them.
- To contextualize these metrics, consider that out of all US stocks, COMPASS THERAPEUTICS INC's average analyst price target is higher than 374.68% of them.
- COMPASS THERAPEUTICS INC's number of analysts covering the stock is greater than 2410.28% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, COMPASS THERAPEUTICS INC's variance in analysts' estimates is lower than -1516.72% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COMPASS THERAPEUTICS INC are ENGN, VIGL, and HLVX.
View All Top Stocks by Price Target
Make investment decisions regarding CMPX using the data that counts. Try POWR Ratings for free.